Gyre Therapeutics (GYRE) Asset Utilization Ratio (2011 - 2026)
Gyre Therapeutics' Asset Utilization Ratio came in at 0.66 for Q2 2026, down 11.2% from 0.74 a year earlier but up 5.1% from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
For FY2025, Gyre Therapeutics' Asset Utilization Ratio was 0.68, down 22.7% from FY2024.
- Asset Utilization Ratio has declined in each of the last three years.
- Going back by year, Asset Utilization Ratio was 0.87 in FY2024 (-22.4%), 1.13 in FY2023 (-22.6%), 1.46 in FY2022 and 0.10 in FY2021 (-55.0%).
- The five-year range for quarterly Asset Utilization Ratio is 0.06 (Q3 2022) to 16.80 (Q3 2023).
- Year-over-year, Asset Utilization Ratio has declined for ten consecutive quarters, with an average decline of 32.4% over the last eight quarters.
- The fastest year-over-year change in Asset Utilization Ratio over five years came in Q1 2022 (growth of 145.7%), and the weakest in Q3 2024 (a decline of 94.9%).
- Business Quant data shows GYRE's Asset Utilization Ratio at 0.63 (Q1 2026), 0.63 (Q4 2025) and 0.71 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 0.44 |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 0.47 |
| 10 | Gyre Therapeutics | 777.23 Mn | 579.94 Mn | 26.90 Mn | 0.66 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.66 |
| Mar 31, 2026 | 0.63 |
| Dec 31, 2025 | 0.63 |
| Sep 30, 2025 | 0.71 |
| Jun 30, 2025 | 0.74 |
| Mar 31, 2025 | 0.79 |
| Dec 31, 2024 | 0.84 |
| Sep 30, 2024 | 0.85 |
| Jun 30, 2024 | 0.92 |
| Mar 31, 2024 | 0.97 |
| Dec 31, 2023 | 1.79 |
| Sep 30, 2023 | 16.80 |
| Jun 30, 2023 | 10.00 |
| Mar 31, 2023 | 2.44 |
| Dec 31, 2022 | 1.77 |
| Sep 30, 2022 | 0.06 |
| Jun 30, 2022 | 0.09 |
| Mar 31, 2022 | 0.14 |
| Dec 31, 2021 | 0.11 |
| Sep 30, 2021 | 0.08 |
API Access
Gyre Therapeutics Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();